# Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis

> **NCT02732210** · — · COMPLETED · sponsor: **Amgen** · enrollment: 935 (actual)

## Conditions studied

- Osteoporosis, Age-Related

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02732210
- **Lead sponsor:** Amgen
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2011-07-06
- **Primary completion:** 2014-04-07
- **Final completion:** 2014-04-14
- **Target enrollment:** 935 (ACTUAL)
- **Last updated:** 2022-11-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02732210

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02732210, "Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT02732210. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*